Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Painkillers via Shutterstock

Painkillers can increase your risk of heart attacks, strokes and death

Research has also found that the size of these risks can be predicted.

HIGHER DOSES OF pain killers can increase the risk of non-fatal heart attacks, strokes, and death by about a third.

That’s according to new research published in Online First in The Lancet.

For decades, non-steroidal anti-inflammatory drugs (NSAIDs) have been the cornerstone in managing pain for people with inflammatory disorders like rheumatoid arthritis, and are some of the most commonly used drugs in the world. However, earlier research linked the drugs with gastrointestinal complications. A new generation of pain killers were developed to reduce the side-effects of stomach issues but they were found to have increased the risk of heart attacks and death.

This new study now shows that older types of NSAIDs, such as diclofenac and ibuprofen, are associated with similar risks of heart disease.

Hearth disease

Research found that for every 1,000 people – with a moderate risk of heart disease – given a high-dose pain killer for a year, about three would experience heart attack, of which one would be fatal.

Also, all NSAIDs double the risk of heart failure and produce a two to four times increased risk of serious upper gastrointestinal complications such as bleeding ulcers.

The research combined data on outcomes of over 353,000 patients comparing one NSAID with another NSAID or placebo.

The analysis of patient data also shows that the size of these risks can be predicted, which may help physicians decide which types of patient are best suited to which NSAID regimen.

Read: Rise in ‘designer drugs’ poses serious health risk: UN report>
More: NCA survey finds wide variations in drug pricing in pharmacies nationwide>

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
25 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds